Milwaukee Office
Tel: (414) 277-5303

Elizabeth R. Gebarski

Associate

Elizabeth Gebarski is an attorney in the firm's Health Law Practice Group. Her practice includes advising clients on regulatory and compliance issues, business development, and licensing issues. She is well versed in providing 340B Drug Pricing Program regulatory, compliance, audit, and contract support to covered entities, contract pharmacies, and other key stakeholders. Elizabeth has experience with the following issues:

  • 340B Drug Pricing Program
  • Federal Laws and Guidance
  • State Reimbursement Laws
  • Data Privacy & Security
  • Federal Cybersecurity Laws and Guidance
  • State Law Security Breach Investigations and Notifications
  • State Privacy Laws
  • Pharmaceutical Industry
  • Federal and State Pharmaceutical Laws and Regulations
  • Federal and State Permit and Licensure Issues
  • DEA Requirements for Controlled Substance Distribution and Prescription Dispensing
  • Health Care Transactions
  • CHOW (Change of Ownership) and Regulatory Requirements for Health Care Mergers and Acquisitions
  • Medicaid and Medicare Program Compliance
  • Sexual Rights and Reproductive Justice Issues
  • FDA Regulatory Compliance
  • State and Federal Food, Drug, and Dietary Supplement Labeling Laws

Prior to joining the firm, Elizabeth clerked for the University of Michigan Health System and the U.S. Attorney’s Office for the Eastern District of Wisconsin. In addition to her law degree, Elizabeth holds a Public Policy degree.

Legal Services

  • Health & Life Sciences
  • Health Care Transactions
  • Pharmacy
  • 340B
  • Hospitals & Health Systems
  • Specialty Pharmacy
  • Long-Term Care and Senior Housing
  • Provider/Physician Groups
  • FDA Regulatory Practice
  • Fraud & Abuse Compliance and Litigation
  • Data Privacy & Security

Education and Honors

  • Marquette University Law School (J.D., cum laude, 2013)
  • Marquette Elder's Advisor, Editor-in-Chief
  • Dean's List, Four Semesters
  • CALI Award (highest grade), Managed Healthcare
  • University of Michigan, Gerald R. Ford School of Public Policy (B.A., 2010)
  • James B. Angell Scholar, 2010

Bar Admissions

  • Wisconsin

Professional and Civic Activities

  • State Bar of Wisconsin (Member)
  • Milwaukee Bar Association (Member)
  • State Bar of Wisconsin Health Law Section (Member)
  • American Bar Association (Member)
  • American Health Lawyers Association (Member)

Professional Recognition

  • State Bar of Wisconsin – Pro Bono Honor Society (2015)

Publications and Presentations

05/15/18
OIG Blesses Arrangement Involving "Far Removed" Excluded Person
OIG Monitor

02/02/17
"The Omnibus Guidance is Dead!"
To Be or Not to 340B

08/18/16
“The 340B Drug Pricing Program: Staying Afloat in the Wake of the Omnibus Guidance”
Health, Labor, and Employment Law Institute

06/28/16
"Cyber Health Crisis: How to Manage the Risk"
Health Law Handbook 2016 Edition

06/22/16
"Don’t Expose Your ePHI by Using Vulnerable Third-Party Applications"
Safe and Sound

05/01/16
"Health Law"
Chapter for Annual Survey of Wisconsin Law, 2016 Edition

03/16/16
"Key Takeaway from 340B Conferences – Audits"
To Be or Not To 340B

03/09/16
"Comparing 340B University and the 340B Coalition Conference"
To Be or Not To 340B

02/29/16
"Top Takeaway from 340B University and 340B Coalition Conference"
To Be or Not To 340B

02/24/16
"Federal Agencies Release Guidance on Cyber Sharing"
Safe and Sound

02/03/16
"Unexpected Uncertainty For The 340B Drug Pricing Program"
Law 360

01/11/16
"Site Neutral Payments Put 340B Child Sites in Jeopardy"
To Be or Not to 340B

01/04/16
"Approved – Cybersecurity Act of 2015"
Safe and Sound

12/31/15
"End of Year Thoughts on FTC Data & Security Requirements"
Safe and Sound

12/14/15
"The 340B Drug Pricing Program Omnibus Guidance – Part Two"
Pharmaceutical Compliance Monitor

11/13/15
"The 340B Drug Pricing Program Omnibus Guidance – in Two Parts"
Pharmaceutical Compliance Monitor

10/30/15
"U.S. Senate Encourages Sharing – of Cyber Threat Indicators, That Is"
Safe and Sound

10/22/15
"Don't Forget Child Sites Under The 340B Omnibus Guidance"
Law360

10/19/15
"PhRMA 2-0 in The Orphan Drug Wars"
To Be or Not to 340B

10/12/15
"Breaking Down the Proposed Omnibus Guidance – Child Sites"
To Be or Not To 340B

10/01/15
T​he 340B Program Mega Guidance: Muddying the Water for All Stakeholders
Health Law Alert

09/17/15
"Breaking Down the Proposed Omnibus Guidance – Covered Entity Eligibility, Registration & Termination"
To Be or Not to 340B

08/28/15
"The Proposed 340B Drug Pricing Program Omnibus Guidelines Have Landed
To Be or Not To 340B

08/19/15
"Target Settles with Visa Card Issuers for Up to $67 Million"
Safe and Sound

06/22/15
"Health Law"
Chapter for Annual Survey of Wisconsin Law, 2015 Edition

06/18/15
"Finally! HRSA Proposes Manufacturer Civil Monetary Penalties"
To Be or Not To 340B

05/28/15
"Near Miss on Congressional Overhaul of 340B Program"
To Be or Not To 340B

05/14/15
"How Much Will You Pay for an Inaccurate 340B Ceiling Price?"
To Be or Not To 340B

05/14/15
Are You Interested in the FDA's Guidance on Outsourcing Facilities? Your Time to Comment Is Ending Soon!
Health Law Alert

05/06/15
"Key Dates Approaching for Title X Family Planning Grantees in the 340B Program"
To Be Or Not To 340B